Candida utilis candidaemia in neonatal patients

J Med Microbiol. 2011 Jun;60(Pt 6):838-841. doi: 10.1099/jmm.0.023408-0. Epub 2011 Feb 24.


In recent years, an evident rise in the frequency of candidaemia caused by non-albicans Candida species has been reported. In this paper we present three cases of clinically manifested candidaemia caused by Candida utilis in neonatal patients hospitalized in the same neonatal intensive care unit within a 6 month period. To the authors' knowledge, only two cases of C. utilis candidaemia have been reported in the literature to date, but neither of these involved newborns. Clinical resolution and elimination of C. utilis from the blood were achieved using liposomal amphotericin B or caspofungin in all patients.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / administration & dosage
  • Antifungal Agents / administration & dosage
  • Candida / isolation & purification*
  • Candidemia / diagnosis*
  • Candidemia / drug therapy
  • Candidemia / microbiology
  • Caspofungin
  • Echinocandins / administration & dosage
  • Female
  • Humans
  • Infant, Newborn
  • Lipopeptides
  • Male
  • Molecular Typing
  • Mycological Typing Techniques
  • Random Amplified Polymorphic DNA Technique
  • Treatment Outcome


  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • liposomal amphotericin B
  • Amphotericin B
  • Caspofungin